Advanced hepatocellular carcinoma with MET-amplified contained excellent response to crizotinib: a case report.

Frontiers in oncology(2023)

引用 0|浏览3
暂无评分
摘要
We report that a patient with high MET amplification benefited from its inhibitor, which was recommended by NGS. This indicates the potential clinical decision support value of NGS and the satisfactory effect of MET inhibitors.
更多
查看译文
关键词
hepatocellular carcinoma, next-generation sequencing, MET, targeted therapy, comprehensive cancer therapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要